NEW SITE — FASTER TURNAROUND, MORE LABS. READ ON
Peptide testing

Ordered GHK-Cu from ZePeptide? Mail in a sample (US only) and let us test it.

Test my supply
+15 more ↓
79%
Finnrick rating
#139 of 156 GHK-Cu vendors
8 of 11 classifiable tests passed
natural 73% · customers 4.6★ (17)
methodology · Purity focus
Finnrick analysis · GHK-Cu

ZePeptide's GHK-Cu record weakened after early clean identity/purity/fill passes, with a +51% overfill followed by a 99.3% purity miss under this methodology. Batch IDs are inconsistent, so newer tests carry the main signal.

methodology →
vendor intelligence report
Vendor Intelligence Report: ZePeptide

Linked storefronts share analytics, pricing and enterprise blocks while making conflicting official-domain and COA-site claims. The report follows domain churn, Nanjing/Zetai/QIN BGLITAI identity trails, COA manufacturer fields and irreversible payment rails.

36 pages9 risk factors assessed12 Nov 2026
read the report
Peptides
#
Peptide
$/MG
Rating
N
1
GHK-Cuselected
$0.07
79%
11
2
Tirzepatide
$0.60
76%
7
3
PT-141
$6.50
68%
4
4
Retatrutide
$1.07
67%
43
5
Tesamorelin
$2.20
63%
8
6
Ipamorelin
$0.72
61%
3
7
BPC-157
$0.70
52%
11
8
TB-500
$1.80
45%
7
9
MOTS-c
$0.56
34%
3
10
NAD+
$0.02
27%
4
11
Wolverine
$0.98
20%
3
13
Cagrilintide
$2.38
-
0
14
CJC-1295
$2.00
-
0
15
CJC-IPA
$1.15
-
0
16
Glutathione
$0.01
-
0
17
IGF-1 LR3
$45.00
-
0
18
KLOW
-
-
0
19
KPV
$0.69
-
0
20
Melanotan II
$0.62
-
0
22
Semax
$0.72
-
0
23
Sermorelin
$1.42
-
0
Contact channels
Rating trend
CUMULATIVE FINNRICK RATING
83%+65%+48%+30%+<30%17 Dec 2025: 88%26 Jan 2026: 90%4 Feb 2026: 90%15 Feb 2026: 91%28 Apr 2026: 87%13 May 2026: 82%10 Jul 2026: 83%13 Jul 2026: 83%3 Aug 2026: 78%9 Aug 2026: 79%6 Oct 2026: 79%15 Nov 2026: current 79%88%87%79%Dec 25Nov 26
Showing GHK-Cu tests only
ZePeptide GHK-Cu test history
COA-backed lab tests
1-10 of 11

About ZePeptide test results from Finnrick

ZePeptide is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 11 peptides and 104 tests, including ratings, observed price signals, recent test dates, and correction history where available.

Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.

The most visible ZePeptide peptides in this dataset are BPC-157 (11 tests), GHK-Cu (11 tests) and Ipamorelin (3 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.

Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 104 recent tests. It also includes 2 corrections related to this vendor.

Corrections
2026-07-29
Finnrick data entry
During data capture from photographs of sample **9gsfxvk**, the crimp color was incorrectly recorded as **Golden** instead of **Silver**. Verification against the corresponding Certificate of Analysis (COA) confirmed that the correct crimp color is **Silver**. The record has been updated to reflect the information provided in the COA.
2026-07-29
Finnrick data entry
During data capture from photographs of sample **d424uhz**, the crimp color was incorrectly recorded as **silver** instead of **gold**. Verification against the corresponding Certificate of Analysis (COA) confirmed that the correct crimp color is **gold**. The record has been updated to reflect the information provided in the COA.
Peptide testing

Ordered GHK-Cu from ZePeptide? Mail in a sample (US only) and let us test it.

Test my supply